|
1
|
Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases.
|
Circulation
|
2004
|
1.65
|
|
2
|
Novel porous aortic elastin and collagen scaffolds for tissue engineering.
|
Biomaterials
|
2004
|
1.24
|
|
3
|
Elastin stabilization for treatment of abdominal aortic aneurysms.
|
Circulation
|
2007
|
1.22
|
|
4
|
Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves.
|
Biomaterials
|
2005
|
1.21
|
|
5
|
Structural requirements for stabilization of vascular elastin by polyphenolic tannins.
|
Biomaterials
|
2006
|
1.17
|
|
6
|
Osteogenic responses in fibroblasts activated by elastin degradation products and transforming growth factor-beta1: role of myofibroblasts in vascular calcification.
|
Am J Pathol
|
2007
|
1.16
|
|
7
|
Fabrication of cardiac patch with decellularized porcine myocardial scaffold and bone marrow mononuclear cells.
|
J Biomed Mater Res A
|
2010
|
1.15
|
|
8
|
Elastin stabilization in cardiovascular implants: improved resistance to enzymatic degradation by treatment with tannic acid.
|
Biomaterials
|
2004
|
1.07
|
|
9
|
Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall.
|
Biomaterials
|
2005
|
1.03
|
|
10
|
Elastin calcification in the rat subdermal model is accompanied by up-regulation of degradative and osteogenic cellular responses.
|
Am J Pathol
|
2006
|
1.03
|
|
11
|
Assembly and testing of stem cell-seeded layered collagen constructs for heart valve tissue engineering.
|
Tissue Eng Part A
|
2010
|
0.99
|
|
12
|
Stabilized collagen scaffolds for heart valve tissue engineering.
|
Tissue Eng Part A
|
2009
|
0.95
|
|
13
|
Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves.
|
Biomaterials
|
2007
|
0.93
|
|
14
|
Glycosaminoglycan-targeted fixation for improved bioprosthetic heart valve stabilization.
|
Biomaterials
|
2006
|
0.90
|
|
15
|
Design and Testing of a Pulsatile Conditioning System for Dynamic Endothelialization of Polyphenol-Stabilized Tissue Engineered Heart Valves.
|
Cardiovasc Eng Technol
|
2010
|
0.89
|
|
16
|
Toward cell therapy for vascular calcification: osteoclast-mediated demineralization of calcified elastin.
|
Cardiovasc Pathol
|
2007
|
0.89
|
|
17
|
Macrophage differentiation and polarization on a decellularized pericardial biomaterial.
|
Biomaterials
|
2010
|
0.88
|
|
18
|
In vivo cellular repopulation of tubular elastin scaffolds mediated by basic fibroblast growth factor.
|
Biomaterials
|
2007
|
0.87
|
|
19
|
Polyphenol-stabilized tubular elastin scaffolds for tissue engineered vascular grafts.
|
Tissue Eng Part A
|
2009
|
0.85
|
|
20
|
Novel tissue-derived biomimetic scaffold for regenerating the human nucleus pulposus.
|
J Biomed Mater Res A
|
2010
|
0.85
|
|
21
|
Inflammation in cardiovascular tissue engineering: the challenge to a promise: a minireview.
|
Int J Inflam
|
2011
|
0.84
|
|
22
|
Structural and biomechanical characterizations of porcine myocardial extracellular matrix.
|
J Mater Sci Mater Med
|
2012
|
0.84
|
|
23
|
Regenerative potential of decellularized porcine nucleus pulposus hydrogel scaffolds: stem cell differentiation, matrix remodeling, and biocompatibility studies.
|
Tissue Eng Part A
|
2013
|
0.83
|
|
24
|
Mitigation of diabetes-related complications in implanted collagen and elastin scaffolds using matrix-binding polyphenol.
|
Biomaterials
|
2012
|
0.83
|
|
25
|
The acellular myocardial flap: a novel extracellular matrix scaffold enriched with patent microvascular networks and biocompatible cell niches.
|
Tissue Eng Part C Methods
|
2013
|
0.82
|
|
26
|
Janus magnetic cellular spheroids for vascular tissue engineering.
|
Biomaterials
|
2013
|
0.82
|
|
27
|
Platform technologies for decellularization, tunic-specific cell seeding, and in vitro conditioning of extended length, small diameter vascular grafts.
|
Tissue Eng Part C Methods
|
2014
|
0.79
|
|
28
|
Small noncytotoxic carbon nano-onions: first covalent functionalization with biomolecules.
|
Chemistry
|
2010
|
0.78
|